Deutsche Rohstoff AG

  • WKN: A0XYG7
  • ISIN: DE000A0XYG76
  • Land: Deutschland

Nachricht vom 18.10.2021 | 09:19

Deutsche Rohstoff AG: Cub Creek Energy successfully completes purchase of acreage in Wyoming

DGAP-News: Deutsche Rohstoff AG / Key word(s): Miscellaneous
18.10.2021 / 09:19
The issuer is solely responsible for the content of this announcement.

Deutsche Rohstoff AG: Cub Creek Energy successfully completes purchase of acreage in Wyoming
30,000 net acres/804 BOE daily production

Mannheim/Denver. Cub Creek Energy has completed the purchase of approximately 30,000 net acres (121 square kilometers) in Wyoming, USA. In addition to the acreage, the purchase agreement includes interests in 17 producing wells with net daily production of approximately 804 barrels of oil equivalent (BOE) as of August 2021.

Cub Creek had signed a purchase agreement in early September and the due diligence check did not reveal any negative findings. Cub Creek will take over the existing production in early November. In the coming months, the development of the undrilled acreage will be intensified and a concept will be prepared. At the same time, Cub Creek will apply for drilling permits in order to be able to start a first drilling program next year.

Mannheim, 18 October 2021

Deutsche Rohstoff identifies, develops and sells attractive raw material deposits in North America, Australia and Europe. The focus is on the development of oil and gas deposits in the USA. Metals such as gold and tungsten complete the portfolio. Further information can be found at www.rohstoff.de

Contact
Deutsche Rohstoff AG
Dr. Thomas Gutschlag, CEO
Phone +49 621 490 817 0
info@rohstoff.de



18.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Symrise verlängert Vorstandsvertrag von Dr. Heinz-Jürgen Bertram vorzeitig bis 2025

01. Dezember 2021, 15:38

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

Bio-Gate AG

Original-Research: Bio-Gate AG (von GBC AG): Kaufen

02. Dezember 2021